We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Eton Pharmaceutcials
ETON
$1.14B
| $22K | ﹤0.01% |
+1,303
| New | +$22.9K |
|
1527
PepGen
PEPG
$201M
| $21.8K | ﹤0.01% |
3,341
+2,073
| +163% | +$10.8K |
|
1528
Owens Corning
OC
$12.3B
| $21.5K | ﹤0.01% |
192
-2,397
| -93% | -$281K |
|
1529
Solid Biosciences
SLDB
$971M
| $21.4K | ﹤0.01% |
3,786
+776
| +26% | +$4.21K |
|
1530
SIGA Technologies
SIGA
$206M
| $21.3K | ﹤0.01% |
3,480
+712
| +26% | +$5.06K |
|
1531
Evolus
EOLS
$536M
| $20.9K | ﹤0.01% |
3,150
+649
| +26% | +$4.4K |
|
1532
4D Molecular Therapeutics
FDMT
$621M
| $20.8K | ﹤0.01% |
2,776
+970
| +54% | +$9.84K |
|
1533
Immuneering
IMRX
$328M
| $20.6K | ﹤0.01% |
+3,138
| New | +$20.1K |
|
1534
Kyverna Therapeutics
KYTX
$489M
| $20K | ﹤0.01% |
2,128
+456
| +27% | +$3.38K |
|
1535
Kamada
KMDA
$397M
| $19.8K | ﹤0.01% |
+2,803
| New | +$19.4K |
|
1536
Cipher Digital
CIFR
$7.42B
| $19.6K | ﹤0.01% |
1,331
+235
| +21% | +$4.15K |
|
|
AUTL
1537
Autolus Therapeutics
AUTL
$564M
| $19.4K | ﹤0.01% |
9,748
+1,994
| +26% | +$3.06K |
|
|
HTT
1538
High Templar Tech Ltd
HTT
$391M
| $19.3K | ﹤0.01% |
5,433
| – | – |
|
1539
Entrada Therapeutics
TRDA
$299M
| $19.1K | ﹤0.01% |
1,857
+386
| +26% | +$3.25K |
|
|
SWKH
1540
DELISTED
SWK Holdings
SWKH
| $19K | ﹤0.01% |
1,105
| – | – |
|
|
NXRT
1541
NexPoint Residential Trust
NXRT
$631M
| $19K | ﹤0.01% |
630
+160
| +34% | +$4.9K |
|
|
TECX
1542
Tectonic Therapeutic
TECX
$720M
| $19K | ﹤0.01% |
909
+186
| +26% | +$3.46K |
|
1543
Columbia Sportswear
COLM
$2.88B
| $19K | ﹤0.01% |
344
-38
| -10% | -$2.03K |
|
1544
Lemonade
LMND
$4B
| $18.9K | ﹤0.01% |
266
+45
| +20% | +$3.02K |
|
|
SAFE
1545
Safehold
SAFE
$1.09B
| $18.7K | ﹤0.01% |
1,363
+342
| +33% | +$4.86K |
|
1546
ACI Worldwide
ACIW
$5.33B
| $18.6K | ﹤0.01% |
390
+71
| +22% | +$3.44K |
|
|
WSR
1547
DELISTED
Whitestone REIT
WSR
| $18.6K | ﹤0.01% |
1,342
+394
| +42% | +$5.08K |
|
1548
Rocket Pharmaceuticals
RCKT
$374M
| $18.5K | ﹤0.01% |
5,259
+1,087
| +26% | +$3.72K |
|
1549
Altimmune
ALT
$570M
| $18.3K | ﹤0.01% |
5,070
+1,658
| +49% | +$7.23K |
|
1550
Yeti Holdings
YETI
$3.85B
| $18.2K | ﹤0.01% |
412
-115
| -22% | -$4.42K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.